These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 180981)

  • 21. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM; Khosla MC
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex.
    Oshima G; Hiraga Y; Shirono K; Oh-ishi S; Sakakibara S; Kinoshita T
    Experientia; 1985 Mar; 41(3):325-8. PubMed ID: 2982643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressor and stereoidogenic actions of [des-Asp1]angiotensin I dependency on conversion to angiotensin III.
    Vaughan ED; Peach MJ; Ackerly JA; Tsai BS; Larner A
    Circ Res; 1977 May; 40(5 Suppl 1):I94-7. PubMed ID: 858177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
    Campbell WB; Schmitz JM; Itskovitz HD
    Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of angiotensin III from [des-Asp1]angiotensin I in the mesentric vasculature.
    Sexton JM; Britton SL; Beierwaltes WH; Fiksen-Olsen MJ; Romero JC
    Am J Physiol; 1979 Aug; 237(2):H218-23. PubMed ID: 464116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct evidence for the presence of a different converting enzyme in the hamster cheek pouch.
    Cornish KG; Joyner WL; Gilmore JP
    Circ Res; 1979 Apr; 44(4):540-4. PubMed ID: 218748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A glial high-affinity binding site with specificity for angiotensin II not angiotensin III: a possible N-terminal-specific converting enzyme.
    Printz MP; Jennings C; Healy DP; Kalter V
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S62-8. PubMed ID: 2438494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate specificity of tonin from rat submaxillary gland.
    Schiller PW; Demassieux S; Boucher R
    Circ Res; 1976 Nov; 39(5):629-32. PubMed ID: 184974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
    Ritter JM; Cockcroft JR; Sciberras DG; Goldberg MR
    J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo conversion of [des-Asp1]-angiotensin I to [des-Asp1]-angiotensin II in conscious sheep.
    Fei DT; Coghlan JP; Scoggins BA; Tresham JJ
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():41-4. PubMed ID: 6754185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Direct cardiac effects of angiotensins I and II and 2 converting enzyme inhibitors (captopril and perindopril). Indirect demonstration of a converting enzyme in the rat heart].
    Diebold H; Moreau D; Chardigny JM; Rochette L
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():29-32. PubMed ID: 2847675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin, angiotensins, and angiotensin-converting enzyme in neuroblastoma cells: evidence for intracellular formation of angiotensins.
    Okamura T; Clemens DL; Inagami T
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6940-3. PubMed ID: 6273896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the angiotensin I converting enzyme of the lung by a peptide fragment of bradykinin.
    Oshima G; Erdös EG
    Experientia; 1974 Jul; 30(7):733-4. PubMed ID: 4367995
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
    Carvalho MB; Duarte FV; Faria-Silva R; Fauler B; da Mata Machado LT; de Paula RD; Campagnole-Santos MJ; Santos RA
    Hypertension; 2007 Oct; 50(4):762-7. PubMed ID: 17664388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of angiotensin I to angiotensin II.
    Erdös EG
    Am J Med; 1976 May; 60(6):749-59. PubMed ID: 190881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heme peroxidase-catalyzed iodination of human angiotensins and the effect of iodination on angiotensin converting enzyme activity.
    Bhuyan BJ; Mugesh G
    Inorg Chem; 2008 Aug; 47(15):6569-71. PubMed ID: 18598023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor stimulates angiotensin converting enzyme activity.
    Kawaguchi H; Sawa H; Iizuka K; Yasuda H
    J Hypertens; 1990 Feb; 8(2):173-7. PubMed ID: 2162881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of atrial natriuretic factor on angiotensin converting enzyme.
    Kawaguchi H; Sawa H; Yasuda H
    J Mol Cell Cardiol; 1989 Oct; 21(10):959-61. PubMed ID: 2555527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.